Barclays Downgrades DBV Technologies S.A (DBVT) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Stifel Downgrades DBV Technologies S.A (DBVT) to Hold
December 20, 2018 4:38 AM ESTStifel analyst Derek Archilia downgraded DBV Technologies S.A (NASDAQ: DBVT) from Buy to Hold with a price target of $11.00 (from $35.00).
The analyst comments "We are certainly disappointed with news of DBVT's decision to withdraw its BLA for Viaskin peanut based on its... More
Jefferies Downgrades DBV Technologies S.A (DBVT) to Hold
December 20, 2018 4:37 AM ESTJefferies analyst Eun Yang downgraded DBV Technologies S.A (NASDAQ: DBVT) from Buy to Hold with a price target of $8.00 (from $37.00).
The analyst comments "Aside from unexpected withdrawal of the Viaskin Peanut (VP) application from the FDA, DBVT's lack of details about next... More
